Avrobio Inc reported $-32246000 in EBITDA for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Akebia Therapeutics AKBA:US $ -45.4M 24.43M
Alnylam Pharmaceuticals ALNY:US $ -169.89M 35.54M
Applied Genetic Technologies AGTC:US $ -15.64M 2.66M
Bluebird Bio BLUE:US $ -190.8M 44.05M
Epizyme EPZM:US $ -62.82M 6.9M
Gilead Sciences GILD:US $ 4370M 1605M
Intercept Pharmaceuticals ICPT:US $ -5.41M 6.8M
Karyopharm Therapeutics KPTI:US $ -43626000 5.19M
Macrogenics MGNX:US $ -50191000 12.69M
Pfizer PFE:US $ 10235M 2245M
Sangamo Biosciences SGMO:US $ -45.88M 0.57M
Sarepta Therapeutics SRPT:US $ -23.96M 135.16M
Takeda 4502:JP Y 238074M 153426M